The use of IORT at Universitätsmedizin Mannheim hospital

Applying the syndemic framework to cancer research for effective cancer control in LMICs

Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC

The multidisciplinary team (MDT) approach and quality of care

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

The importance of providing post-treatment care to cancer survivors

Cancer Survivorship

The clinical impact of the Choosing Wisely project

Why tumour markers are not recommended as screening tests

Key practices for handling difficult conversations in cancer care

Choosing wisely in complementary treatment for cancer in the Philippines